Vanda Pharmaceuticals Inc
NASDAQ:VNDA

Watchlist Manager
Vanda Pharmaceuticals Inc Logo
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Watchlist
Price: 4.33 USD 2.12% Market Closed
Market Cap: 255.2m USD

Intrinsic Value

The intrinsic value of one VNDA stock under the Base Case scenario is 7.73 USD. Compared to the current market price of 4.33 USD, Vanda Pharmaceuticals Inc is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VNDA Intrinsic Value
7.73 USD
Undervaluation 44%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Vanda Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for VNDA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Vanda Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vanda Pharmaceuticals Inc

Current Assets 438.9m
Cash & Short-Term Investments 374.6m
Receivables 47.1m
Other Current Assets 17.1m
Non-Current Assets 217.3m
PP&E 12.7m
Intangibles 114.1m
Other Non-Current Assets 90.5m
Efficiency

Free Cash Flow Analysis
Vanda Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vanda Pharmaceuticals Inc

Revenue
198.8m USD
Cost of Revenue
-11.3m USD
Gross Profit
187.5m USD
Operating Expenses
-228.1m USD
Operating Income
-40.7m USD
Other Expenses
21.8m USD
Net Income
-18.9m USD
Fundamental Scores

VNDA Profitability Score
Profitability Due Diligence

Vanda Pharmaceuticals Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Exceptional Revenue Growth Forecast
Positive 1-Year Revenue Growth
42/100
Profitability
Score

Vanda Pharmaceuticals Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

VNDA Solvency Score
Solvency Due Diligence

Vanda Pharmaceuticals Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
72/100
Solvency
Score

Vanda Pharmaceuticals Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VNDA Price Targets Summary
Vanda Pharmaceuticals Inc

Wall Street analysts forecast VNDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VNDA is 12.92 USD with a low forecast of 5.05 USD and a high forecast of 21 USD.

Lowest
Price Target
5.05 USD
17% Upside
Average
Price Target
12.92 USD
198% Upside
Highest
Price Target
21 USD
385% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Vanda Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VNDA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VNDA Insider Trading
Buy and sell transactions by insiders

VNDA News

Other Videos
What is the Intrinsic Value of one VNDA stock?

The intrinsic value of one VNDA stock under the Base Case scenario is 7.73 USD.

Is VNDA stock undervalued or overvalued?

Compared to the current market price of 4.33 USD, Vanda Pharmaceuticals Inc is Undervalued by 44%.

Back to Top